Morphogen treatment of gastrointestinal ulcers

Details Morphogen treatment of gastrointestinal ulcers Morphogen treatment of gastrointestinal ulcers

1995-06-05

1999-10-26

Walsh, Stephen

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 530350, A61K 3818, C07K 1451

Patent

active

059728841

ABSTRACT:
Disclosed are methods and compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation normally associated with ulcerative diseases, and (4) stimulating the repair of ulcerative lesions and the regeneration of the luminal tissue. The methods and compositions include a therapeutically effective amount of a morphogen as defined herein.

REFERENCES:
patent: 4806523 (1989-02-01), Bentz et al.
patent: 4877864 (1989-10-01), Wang et al.
patent: 4919939 (1990-04-01), Baker
patent: 4968590 (1990-11-01), Kuberasampath
patent: 4975526 (1990-12-01), Kuberasampath
patent: 5008240 (1991-04-01), Bentz et al.
patent: 5011691 (1991-04-01), Oppermann et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5043329 (1991-08-01), Lichtenberger
patent: 5091513 (1992-02-01), Huston et al.
patent: 5102870 (1992-04-01), Florine et al.
patent: 5106626 (1992-04-01), Parsons et al.
patent: 5108753 (1992-04-01), Kuberasampath
patent: 5110795 (1992-05-01), Hahn
patent: 5141905 (1992-08-01), Rosen et al.
Gennaro (1990) Remington's Pharmaceutical Sciences (Mack Pubs., N.Y.).
Massague (1987), Cell, vol. 49, pp. 437-438.
Pepinsky et al. (1988) Journal of Biological Chemistry, vol. 263, pp. 18961-18964.
Alper (1993) Science, vol. 260, pp. 159-160.
Nakashima et al. Dentin induction by implants of autolyzed antigen-extracted allogeneic dentin on amputated pulps of dogs. Endodontics and Dental Traumatology, 5:279-286 (1989).
Noda et al. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology, (Jun. 1989) 124 (6) 2991-4.
Beck et al.. Rapid publication. TGF-beta 1 induces bone closure of skull defects. J. Bone Min. Res., (Nov. 1991) 6 (11) 1257-65.
Joyce et al. Role of tranforming growth factor-beta in fracture repair. Ann. N.Y. Acad. Sci., (1990) 593 107-23.
Joyce et al. Role of growth factors in fracture healing. Prog. Clin. Biol. Res., (1991) 365 391-416.
Gitelman et al. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J. Cell Biol., (Sep. 1994) 126 (6) 1595-609.
Rutherford et al. A new biological approach to vitasl pulp therapy. Crit. Rev. Oral Biol. Med. 6(3):218-229(1995).
Rutherford et al. Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1, Arch. Oral Biol., (Jul. 1993) 38 (7) 571-6.
Sporn M B; Roberts A B. A major advance in the use of growth factors to enhance wound healing [editorial]. Journal of Clinical Investigation, (Dec. 1993) 92 (6) 2565-6.
Sonis S T; Lindquist L; Van Vugt A; Stewart A A; Stam K; Qu G Y; Iwata K K; Haley J D. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Research, (Mar. 1, 1994) 54 (5) 1135-8, Apr. 1994.
Shah M; Foreman D M; Ferguson M W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. Journal of Cell Science, (Mar. 1995) 108 ( Pt 3) 985-1002, Apr. 1995.
Kingsley D M. The TGF-beta superfamily: new members, new receptors, and new genetic testsof function in different organisms. Genes and Development, (Jan. 1994) 8 (2) 133-46.
Bowie J U; Reidhaar-Olson J F; Lim W A; Sauer R T. Deciphering the message in proteinsequences: tolerance to amino acid substitutions. Science, (Mar. 16, 1990) 247 (1948) 1306-10.
Ayers CJ. 1989. In Molecular Cell Biology (Addison-Wesley Publishing Company, Reading, MA). p. 803, 1989.
Rosen et al.; Wang et al. and Wozney et al., Calcified Tissue Int. 42 (Suppl.): A35 (Abstract 136), A37 (Abstracts 146, 147) (1988).
Rosen et al. "Purification and Molecular Cloning of a Novel Group of BMPS and Localization of BMP MRNA in Developing Bone," Connective Tissue Res., 20:313-319 (1989).
Wozney "Bone Morphogenetic Proteins," Progress In Growth Factor Research, 1:267-280 (1990).
Rosen et al., Celeste et al., J. Cell Biochem. Suppl., (Suppl. 14E):33 (Abstract 009), 54 (Abstract 105 (1990).
Katagiri et al. "The Non-Osteogenic Mouse Pluripotent Cell Line, C3H10T1/2, is Induced to Differentiate into Osteoblastic Cells by Recombinant Human Bone Morphogenetic Protein-2," Biochem. Biopys. Res. 172 (1):295-299 (1990).
Wozney et al. "Growth Factors Influencing Bone Development," Journal Of Cell Science Suppl., 13:149-156 (1990).
Takuwa et al. "Bone Morphogenetic Protein-2 Stimulates Alkaline Phosphatase Activity and Collagen Synthesis in Cultured Osteoblastic Cells, MC3T3-E1," Biochem. Biophys. Res. Comm, 174(1):96-101 (1991).
Yamaguchi et al. "Recombinant Human Bone Morphogenetic Protein-2 Stimulates Osteoblastic Maturation and Inhibits Myogenic Differentiation In Vitro," J. Cell. Biol., 113 (3):681-687 (1991).
D'Alessandro et al., Abstract Q-105. Journal Of Cellular Biochemistry, (1991).
Israel et al., Abstract Q-111 Journal Of Cellular Biochemistry, 1991.
Thies et al. "Recombinant Human Bone Morphogenetic Protein-2 Induces Osteoblastic Differentiation in W-20-17 Stromal Cells," Endocrinology, 130:1318-1324 (1992).
Wozney "The Bone Morphogenetic Protein Family and Osteogenesis," Mol. Reprod. Dev., 32:160-167 (1992).
Rogers et al. "Bone Morphogenetic Proteins-2 and -4 are Involved in the Retinoic Acid-Induced Differentiation of Embryonal Carcinoma Cells," Mol. Biol. Cell, 3:189-196 (1992).
Wozney et al.; Celeste et al.;and Rosen et al., J. Cell Biochem. Suppl. 16F:76(Abstract WO26), 100 (Abstract W502), 103 (Abstract W513) (1992).
Israel et al. "Expression and Characterization of Bone Morphogenetic Protein-2 in Chinese Hamster Ovary Cells," Growth Factors, 7:139-150 (1992).
Padget et al. "Human BMP Sequences Can Confer Normal Dorsal-Ventral Patterning in the Drosophila Embryo," Proc. Natl. Acad. Sci. USA, 90:2905-2909 (1993).
Behringer et al., Nature, 345:167-170 (1990).
Cate et al., Cell, 45:685-698 (1986).
Celeste et al., PNAS, 87:9843-9847 (1990).
Chomczyaski, et al., Anal Biochem., 162:156-159 (1987).
Clark et al., Arch. Biochem. Biophys., 241:36-44 (1985).
Fava et al., J. Exp. Med., 173:1121-1132 (1991).
Gallagher, Current Opinion in Dentistry, 1:777-782 (1991).
Green et al., Nature, 347:391-394 (1990).
Kuberasampath et al., J. Biol. Chem., 265:13198-13205 (1990).
Lee, Molecular Endocrinology, 4:1034-1040 (1990).
Lee, PNAS, 88:4250-4254 (1991).
Lyons et al., PNAS, 86:4554-4558 (1989).
Lyons et al., Genes & Development, 3:1657-1668 (1989).
Mason et al., Nature, 318:659-663 (1985).
Mason et al., Mol. Endocrinology, 3:1352-1358 (1989).
Miller et al., Cancer Research, 42:2589-3594 (1987).
Okayasu et al., Gastroenterology, 98:694-702 (1990).
Onderdonk et al., Am. J. Clin. Nutr. 32 258-265 (1979).
Onderdonk, Dig. Diseases Sci., 30:40S-44S (1985).
Ozkaynak et al., Embo J., 9:2085-2093 (1990).
Ozkaynak et al., Biochem. Biophys. Res. Comm., 179:116-123 (1991).
Padgett et al., Nature, 325:81-84 (1987).
Panganiban et al., Mol. and Cell. Biol., 10:2669-2677 (1990).
Pihan et al., Digest-Diseases & Sci., 30:240-246 (1985).
Postlethwaite et al., J. Clin. Invest., 83:629-636 (1989).
Postlethwaite, J. Cell Biol., 106:311-318 (1988).
Sampath et al., PNAS, 80:6591-6595 (1983).
Schubert et al., Nature, 344:868-870 (1990).
Smith et al., Nature, 345:729-731 (1990).
Sokol et al., Science, 249:561-564 (1990).
Sonis et al., Oral Sug. Oral Med. Oral Pathol, 69:437-443 (1990).
Szabo et al., Res. Comm. Chem. Pathol. Pharmacol., 16:311-323 (1977).
Wang et al., PNAS, 87:2220-2224 (1990).
Wang et al., PNAS, 85:9484-9488 (1988).
Weeks, Cell, 51:861-867 (1987).
Wharton et al., PNAS, 88:9214-9218 (1991).
Wozney et al., Science, 242:1528-1533 (1988).
Yannas, Angew. Chem. Int. Ed. Engl., 29:20-35 (1990).

Affiliated with

Also associated with

Rating

Morphogen treatment of gastrointestinal ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Morphogen treatment of gastrointestinal ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphogen treatment of gastrointestinal ulcers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-764452